论文部分内容阅读
目的:观察复方樟柳碱注射液治疗中心性浆液性脉络膜视网膜病变(CSC)的效果。方法:随机将2015年5月~2016年5月收治的82例CSC患者分为两组,每组41例。对照组采用血管扩张剂、维生素等常规治疗方法,观察组在对照组的基础上行复方樟柳碱注射液治疗,比较两组视力情况、视网膜神经上皮脱离范围等指标。结果:治疗后,观察组视力恢复程度、光敏感度等指标显著优于对照组,差异具有统计学意义(P<0.05),两组均未发现明显不良反应。结论:采用复方樟柳碱注射液治疗CSC效果理想,安全性高。
Objective: To observe the effect of compound anisodine injection in the treatment of central serous chorioretinopathy (CSC). Methods: 82 patients with CSC admitted to our hospital from May 2015 to May 2016 were randomly divided into two groups, 41 patients in each group. The control group was treated with vasodilators and vitamins. The observation group was treated with compound anisodine injection on the basis of the control group. The visual acuity and retinal detachment range were compared between the two groups. Results: After treatment, the degree of visual acuity recovery and light sensitivity in the observation group were significantly better than those in the control group (P <0.05). No obvious adverse reactions were found in both groups. Conclusion: The compound anisodine injection for CSC is effective and safe.